Haven't used Novelion Therapeutics yet?
Ask Trustburn

Ask Trustburn about Novelion Therapeutics

Based on 9 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Jenny Navarijo
Reviews 1

Novelion Therapeutics is an amazing company to work with. The staff is very professional and knowledgeable. They provide top-notch services and their website is extremely user-friendly. I highly recommend their products and services.

Cathy McKone-Simons
Reviews 1

I had a great experience with this company. The products are high quality and the website is user-friendly. The customer service team was very attentive and answered all my questions promptly. I would definitely purchase from them again.

Jarrett Spencer
Reviews 1

I really enjoyed my experience with this company. They have great products and their website is easy to navigate. The customer service team was very helpful and responsive to my inquiries. I would definitely recommend them to others.

Questions & Answers

No questions yet β€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website β€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="novelion-com" data-lang="en"></div>
More widgets

About Novelion Therapeutics

Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.